Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Harvard Business School
McKinsey
Healthtrust
Argus Health
Mallinckrodt

Generated: March 25, 2019

DrugPatentWatch Database Preview

Litigation for EMPAGLIFLOZIN; LINAGLIPTIN

« Back to Dashboard

US Court Litigation for EMPAGLIFLOZIN; LINAGLIPTIN

Patent Case Name Docket Date Filed Date Terminated Cause Court Jury Demand Link To Docket
7,407,955 BOEHRINGER INGELHEIM PHARMACEUTICALS INC. v. HEC PHARM CO., LTD. ➤ Sign Up 2015-08-04 35:271 Patent Infringement District Court, D. New Jersey None ➤ Sign Up
7,713,938 Plaintiff(s) v. Defendant(s) ➤ Sign Up 2018-01-01 no cause specified District Court, D. Delaware None ➤ Sign Up
8,119,648 BOEHRINGER INGELHEIM PHARMACEUTICALS INC. v. HEC PHARM CO., LTD. ➤ Sign Up 2015-08-04 35:271 Patent Infringement District Court, D. New Jersey None ➤ Sign Up
Patent Case Name Docket Date Filed Date Terminated Cause Court Jury Demand Link To Docket

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Patent Trial and Appeal Board Cases for EMPAGLIFLOZIN; LINAGLIPTIN

Patent Petitioner Status Filing Date Accorded Filing Date Patent Owner Trial Type Trial Number Decision Date Inventor Document Download
8,673,927 Mylan Pharmaceuticals Inc. ➤ Sign Up 2016-08-10 2016-08-10 DUGI et al Inter partes review ➤ Sign Up 2017-02-03 ➤ Sign Up
8,846,695 Mylan Pharmaceuticals Inc. ➤ Sign Up 2016-08-10 2016-08-10 Dugi Inter partes review ➤ Sign Up 2017-01-31 ➤ Sign Up
9,173,859 Mylan Pharmaceuticals Inc. ➤ Sign Up 2016-08-10 2016-08-10 DUGI et al Inter partes review ➤ Sign Up 2017-02-03 ➤ Sign Up
Patent Petitioner Status Filing Date Accorded Filing Date Patent Owner Trial Type Trial Number Decision Date Inventor Document Download

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Federal Trade Commission
Deloitte
Harvard Business School
Colorcon
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.